Patrick Yassini, MD
Family Medicine · Coronado, CANPI 1649353095
Payments from drug & device makers
Across 1,705 payments — averaging $1640.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$1.2M
- Seqirus USA Inc$353K
- Pfizer$323K
- Modernatx, Inc.$288K
- Emergent Biosolutions Inc.$250K
- Valneva Austria GmbH$232K
- plus $167K from 12 others
Across 2 payments — averaging $84,549 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$169K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 36 | $1,184,190 |
| Seqirus USA Inc | 161 | $353,058 |
| Pfizer | 26 | $323,177 |
| Modernatx, Inc. | 1,348 | $288,014 |
| Emergent Biosolutions Inc. | 12 | $250,089 |
| Valneva Austria GmbH | 7 | $231,519 |
| Janssen Research & Development, LLC | 9 | $57,829 |
| Incyte Corporation | 18 | $53,356 |
| AbbVie | 30 | $44,230 |
| Dynavax Technologies Corporation | 48 | $10,171 |
| Bavarian Nordic A/s | 2 | $1,300 |
| Lumenis BE Inc | 1 | $142 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Linus Health, Inc. | 1 | $25 |
| Merz North America, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Clarus Therapeutics Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$2,797,215 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Coronado
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.